EU Biopharma Enterp.

EBE is EU’s expert voice for emerging bioscience & technology and the leading platform for the health innovation ecosystem. #biopharma #tech #health #science

[EU Biopharma Enterp. @EBE_EU]

The programme for @EBE_EU’s annual #ATMPs conference "Handling the ATMPs challenges to timely meet #patients needs" is now live! https://t.co/UBJl7qGMt8. Register here: https://t.co/kQW5HtnicH
#advancedtherapies #biotech

[EU Biopharma Enterp. @EBE_EU]

Last chance to register for the @EBE_EU regulatory conference on #ATMPs "Handling the ATMPs challenges to timely meet #patients needs". Registrations will close on 2 December. Register now: https://t.co/kQW5HtnicH

[Sini Eskola @sinieskola]

Landscape of medicines development is rapidly evolving, regulatory science research needs to keep up. Today #RegScience2025 strategy is discussed with stakeholders @EMA_News. @EFPIA @EBE_EU @VaccinesEurope @EUCOPE @EuropaBio @aesgp @medicinesforEU presenting the industry view

[Horizon Europe 🇪🇺 @HorizonEU]

Looking for partners, investors & funding opportunities?
The 25th annual #BIOEurope @EBDgroup is almost here!
📆Join us on 12 Nov from 9am to find out about #H2020 support, and meet us at the #EU booth 92 at the exhibition
👉 https://t.co/VzgB1lDkiQ
#InvestEUResearch

[Innovative Health Initiative @IHIEurope]

Our October newsletter is out, with info on the new health PPP, the next IMI Calls, plus news from our projects @IMIConcePTION @RADARAD7 @FAIRplus_eu & our #Ebola programme
Read it online + sign up for future editions: https://t.co/mn1Itq02B5
#IMICarryTheTorch #EUHealthResearch

[Magda @MagdaEfpia]

Have your say on the research roadmap for the proposed Health Innovation PPP under Horizon Europe - deadline 24 November!
The research agenda and the online survey are here: https://t.co/gsmzX493Bx #EUHealthPPP

[EFPIA @EFPIA]

30 million people in Europe live with a #raredisease. #WeWontRest until we make rare diseases even rarer #Care4Rare https://t.co/dLxjn48Aot

[Innovative Health Initiative @IHIEurope]

Read IMI's September newsletter, featuring Pierre Meulien on #AdvancedTherapies + stories from our projects on #Ebola #SLCs #SocialMedia & #Pharmacovigilance + #iPSC
Read it online & sign up for future issues https://t.co/5Erx6XpNGx
#IMICarryTheTorch #EUHealthResearch #H2020

[Innovative Health Initiative @IHIEurope]

Our June newsletter is out, with news on our latest Calls for proposals, plus updates from our events this month
Read it online: https://t.co/GZuYVa5kjY
Sign up to receive future issues: https://t.co/mn1Itq02B5
#IMICarryTheTorch #H2020 #EUHealthResearch

[Innovative Health Initiative @IHIEurope]

Press release: Advanced therapies feature in new IMI Calls for proposals (+ #AI in pathology, healthcare info, health outcomes, cancer trials)
Press release https://t.co/x1qAk8hU5R
Call 18 https://t.co/AMmWuSHFlO
Call 19 https://t.co/oK8plxUyLZ
#H2020 #EUHealthResearch

[European Cancer Organisation @EuropeanCancer]

Eye on Brussels: Read the @EuropeanCancer report from the @EFPIA #OncologyDataSummit last week https://t.co/Z8Rw5esGet #oncology #oncologydata #cancercare

[EU Medicines Agency @EMA_News]

Only one week left to share your ideas and suggestions with us on EMA's Regulatory Science Strategy to 2025. Your feedback is very important to help us ensure a thorough assessment of ground-breaking, more complex therapies. #RegScience2025
👉https://t.co/xmCyJcI9ky

[WIN Consortium @WIN_Consortium]

Policy and barriers to Personalized medicines for European Healthcare Systems, Anthony Barron
@EFPIA #winsympo2019
@WIN_Consortium

[WIN Consortium @WIN_Consortium]

Today’s expert panel interact with the audience on the issues surrounding disruptive concepts and innovation across the globe #winsympo2019
@mcgillu @MDAndersonNews King Hussein Cancer Centre @EFPIA
@djtweardy @VivekSubbiah @Dr_R_Kurzrock

[WIN Consortium @WIN_Consortium]

We are excited to announce our 2019 corporate partners - browse through them and learn more about who you’ll be meeting at the #winsympo2019! https://t.co/38VLdwgmvC

[WIN Consortium @WIN_Consortium]

Wondering about which sessions to attend at the #winsympo2019? Make a note of 'Addressing Mechanisms of Resistance Following Anti-Cancer Therapy: a Pharma Perspective’ delivered by Jean-François Martini, Ph.D., MSc. https://t.co/avnAsivBw1

[WIN Consortium @WIN_Consortium]

We will be meeting very shortly in Paris for the #winsympo2019! Use this opportunity to plan ahead and be ready for your trip to France’s capital. Find some tips on what to expect and what to see at: https://t.co/K7PKOK4PPy

[EU Medicines Agency @EMA_News]

What should regulators do to keep pace with scientific advances in medicine 💊development? We want to hear your suggestions. #RegScience2025
👉https://t.co/xmCyJcI9ky

[Innovative Health Initiative @IHIEurope]

IMI reassures me because we have 11 years of proof that we can collaborate- the sum is greater than the parts, and it excites me because the prospects are endless, says @EFPIA’s @NathalieMoll wrapping up our Stakeholder Forum #IMICarryTheTorch

[EU Biopharma Enterp. @EBE_EU]

.@EBE_EU's Biomanufacturing Working Group released today their latest reflection paper on medicinal product incorporating a drug delivery device component: An Industry Perspective on developing an efficient, ‘End to End’ Control Strategy":https://t.co/s83Ch5uC6S